Our World
Contact Us

Press Releases

Biocon Biologics  /  Press Releases

Biocon Q1FY19 Revenue Rs 1,193 Cr, Up 21%; EBITDA Up 25% at Rs 307 Cr; Net Profit Up 47% at Rs 120 Cr
  • Thu, 26-Jul-2018
  • Posted by: Biocon Biologics
No Comments

Kiran Mazumdar-Shaw Elected Full-Term Member of the Board of Trustees of MIT, USA
  • Thu, 28-Jun-2018
  • Posted by: Biocon Biologics
No Comments

U.S. FDA Approves Mylan and Biocon’s Fulphila™ (pegfilgrastim-jmdb), the First Biosimilar to Neulasta®
  • Tue, 05-Jun-2018
  • Posted by: Biocon Biologics
No Comments

Tata Memorial Hospital Team Presents Biocon’s Nimotuzumab Study Results at ASCO Annual Meeting 2018
  • Mon, 04-Jun-2018
  • Posted by: Biocon Biologics
No Comments

Mylan and Biocon to Present New Data at the American Society of Clinical Oncology (ASCO) Annual Meeting Reinforcing the Efficacy, Safety and Immunogenicity of Ogivri™, the first biosimilar for Herceptin®, approved by US FDA
  • Sat, 02-Jun-2018
  • Posted by: Biocon Biologics
No Comments

Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27%; EBITDA Up 30% at Rs 300 Cr; Net Profit Up 2% at Rs 130 Cr
  • Thu, 26-Apr-2018
  • Posted by: Biocon Biologics
No Comments

Kiran Mazumdar-Shaw #1 Business Captain in ‘The Medicine Maker 2018 Power List’
  • Wed, 18-Apr-2018
  • Posted by: Biocon Biologics
No Comments

Mylan and Biocon Receive Approvals from the European Commission and TGA, Australia for Semglee™ Biosimilar Insulin Glargine
  • Wed, 28-Mar-2018
  • Posted by: Biocon Biologics
No Comments

Mylan and Biocon Receive Positive CHMP Opinion for Semglee™, Biosimilar Insulin Glargine
  • Mon, 29-Jan-2018
  • Posted by: Biocon Biologics
No Comments

Biocon Q3FY18 Revenue at Rs 1092 Crore; EBITDA at Rs 256 Crore; Net Profit at Rs 92 Crore
  • Wed, 24-Jan-2018
  • Posted by: Biocon Biologics
No Comments
Report adverse events/side effects/product complaints and/or to submit medical inquiries for Biocon Biologics Limited & BBL Affiliate products.

* Cookie Policy | Privacy Policy | Terms of Use © 2025, Biocon Biologics Limited (a Subsidiary of Biocon Limited). All Rights Reserved
Share
buy twitter followers - omegle - matadorbet güncel adres - onwin - onwin güncel adres